Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-271 from the NIH Guide for Grants and Contracts. The goal of this FOA is identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists of disease target(s) for therapy or immunotherapy. The FOA is intended to support discovery research for the identification of validated hits relevant to health-related outcomes of participating NIH Institutes. Stages of discovery research covered by this FOA include: 1) assay development for specific biological targets and disease mechanisms relevant to the mission of participating...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 20, 2020 Category: Research Source Type: funding
Notice of Change to Key Dates for PAR-19-040 "Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)"
Notice NOT-NS-20-088 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 10, 2020 Category: Research Source Type: funding
Notice of Change to Key Dates for PAR-19-039 "Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)"
Notice NOT-NS-20-087 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 10, 2020 Category: Research Source Type: funding
Notice of Change to Key Dates for PAR-18-657 "Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)".
Notice NOT-NS-20-086 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 10, 2020 Category: Research Source Type: funding
Notice of New Budget Limitation for PAR-18-657 "Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)"
Notice NOT-NS-20-085 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 8, 2020 Category: Research Source Type: funding
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-253 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for NIH Countermeasures Against Chemical Threats (CounterACT) exploratory/developmental (R21) projects. The mission of the NIH CounterACT program is to foster and support research that will advance development of new and improved therapeutics to mitigate the health effects of chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical wa...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 7, 2020 Category: Research Source Type: funding
Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-232 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites exploratory/developmental applications that propose transformative engineering solutions to technical challenges associated with meaningful development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices to clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of pati...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 16, 2020 Category: Research Source Type: funding
Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-233 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that propose transformative engineering solutions to technical challenges associated with new development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices for clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of patient functional status and clinic...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 16, 2020 Category: Research Source Type: funding
Pilot Projects Increasing the Impact of the NIH Centers for Advancing Research on Botanicals and Other Natural Products (PI2 CARBON) (R03 Clinical Trials Not Allowed)
Funding Opportunity PAR-20-228 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support collaborative pilot research projects focused on potential effects relevant to human health of chemically complex natural products and/or the causal, molecular mechanisms underlying such effects. A critical element of each proposed project must be collaboration with one or more of the NIH Centers for Advancing Research on Botanicals and Other Natural Products (CARBON). More specifically, letters of support describing collaboration with one or more of the U19 Botanical Dieta...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 8, 2020 Category: Research Source Type: funding
Request for Information (RFI): Input to Enhance the Impact of the NCI Experimental Therapeutics Programs Chemical Biology Consortium on Cancer Drug Discovery and Development
Notice NOT-CA-20-071 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 27, 2020 Category: Research Source Type: funding
Division of Chemistry: Disciplinary Research Programs (CHE-DRP)
Available Formats: HTML: https://www.nsf.gov/pubs/2020/nsf20577/nsf20577.htm?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2020/nsf20577/nsf20577.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf20577This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - May 15, 2020 Category: Science Source Type: funding
Centers for Chemical Innovation (CCI)
Available Formats: HTML: https://www.nsf.gov/pubs/2020/nsf20574/nsf20574.htm?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2020/nsf20574/nsf20574.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf20574This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - May 13, 2020 Category: Science Source Type: funding
Multimodal Sensor Systems for Precision Health Enabled by Data Harnessing, Artificial Intelligence, and Learning (SenSE)
Full Proposal Deadline Date: June 8, 2020 Program Guidelines: NSF 20-556The National Science Foundation (NSF) through its Divisions of Electrical, Communications and Cyber Systems (ECCS); Chemical, Bioengineering, Environmental and Transport Systems (CBET); Civil, Mechanical and Manufacturing Innovation (CMMI); Information and Intelligent Systems (IIS); and Mathematical Sciences (DMS) announces a solicitation on Multimodal Sensor Systems for Precision Health enabled by Data Harnessing, Artificial Intelligence (AI), and Learning. Next-generation multimodal sensor ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5...
Source: NSF Upcoming Due Dates - May 9, 2020 Category: Science Source Type: funding
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
Funding Opportunity PA-20-199 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrou...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 7, 2020 Category: Research Source Type: funding
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required)
Funding Opportunity PA-20-197 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrou...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 7, 2020 Category: Research Source Type: funding
